Regulatory strategy vs. regulatory intelligence
Navigating the regulatory landscape of the medical device sector is a complex task, requiring both ...
SCRO is now Aurevia
We are happy to announce that Scandinavian CRO (SCRO) is now operating under the name of Aurevia, ...
QAdvis is now Aurevia – Expanding our capabilities together
QAdvis is now Aurevia – expanding our capabilities together We are happy to announce that QAdvis is ...
Merging expertise: Clinical research and regulatory affairs
In January, Aurevia was established from the merger of five European companies within clinical ...
Ulrika Hammarström appointed new Head of CRO
Last year, Aurevia (formerly LabQuality) acquired Scandinavian CRO. Recently, Ulrika Hammarström, ...
The FDA is being restructured and the world is holding its breath
For nearly 30 years, the U.S. Food and Drug Administration has played a pivotal role in shaping the ...
Health technology assessment regulation
The Health Technology Assessment Regulation (HTAR), officially known as Regulation (EU) 2021/2282, ...
Anna-Karin Alm
QAdvis is delighted to announce that Anna-Karin Alm has joined QAdvis as the new CEO, effective ...
May your holidays be full of warmth and cheer
We at QAdvis want to wish you a joyful holiday season and say thanks for what we have achieved ...